Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Active learning impairments in substance use disorders when resolving the explore-exploit dilemma: A replication and extension of previous computational modeling results

Samuel Taylor, Claire A. Lavalley, Navid Hakimi, Jennifer L. Stewart, Maria Ironside, Haixia Zheng, Evan White, Salvador Guinjoan, Martin P. Paulus, Ryan Smith
doi: https://doi.org/10.1101/2023.04.03.23288037
Samuel Taylor
Laureate Institute for Brain Research, Tulsa, OK, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire A. Lavalley
Laureate Institute for Brain Research, Tulsa, OK, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Navid Hakimi
Laureate Institute for Brain Research, Tulsa, OK, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer L. Stewart
Laureate Institute for Brain Research, Tulsa, OK, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Ironside
Laureate Institute for Brain Research, Tulsa, OK, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haixia Zheng
Laureate Institute for Brain Research, Tulsa, OK, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan White
Laureate Institute for Brain Research, Tulsa, OK, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salvador Guinjoan
Laureate Institute for Brain Research, Tulsa, OK, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin P. Paulus
Laureate Institute for Brain Research, Tulsa, OK, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Smith
Laureate Institute for Brain Research, Tulsa, OK, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rsmith{at}laureateinstitute.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Substance use disorders (SUDs) represent a major public health risk. Yet, our understanding of the mechanisms that maintain these disorders remains incomplete. In a recent computational modeling study, we found initial evidence that SUDs are associated with slower learning rates from negative outcomes and less value-sensitive choice (low “action precision”), which could help explain continued substance use despite harmful consequences.

Methods Here we aimed to replicate and extend these results in a pre-registered study with a new sample of 168 individuals with SUDs and 99 healthy comparisons (HCs). We performed the same computational modeling and group comparisons as in our prior report (doi: 10.1016/j.drugalcdep.2020.108208) to confirm previously observed effects. After completing all pre-registered replication analyses, we then combined the previous and current datasets (N = 468) to assess whether differences were transdiagnostic or driven by specific disorders.

Results Replicating prior results, SUDs showed slower learning rates for negative outcomes in both Bayesian and frequentist analyses (η2=.02). Previously observed differences in action precision were not confirmed. Logistic regressions including all computational parameters as predictors in the combined datasets could differentiate several specific disorders from HCs, but could not differentiate most disorders from each other.

Conclusions These results provide robust evidence that individuals with SUDs have more difficulty adjusting behavior in the face of negative outcomes than HCs. They also suggest this effect is common across several different SUDs. Future research should examine its neural basis and whether learning rates could represent a new treatment target or moderator of treatment outcome.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the NIGMS (P20 GM121312; PI:MPP) and the Laureate Institute for Brain Research.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Western IRB gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

  • Informed consent: Informed consent was obtained from all individual participants included in the study.

  • Funding: This work was funded by the NIGMS (P20 GM121312; PI:MPP) and the Laureate Institute for Brain Research.

  • Conflict of Interest: None of the authors have any conflicts of interest to disclose.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 05, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Active learning impairments in substance use disorders when resolving the explore-exploit dilemma: A replication and extension of previous computational modeling results
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Active learning impairments in substance use disorders when resolving the explore-exploit dilemma: A replication and extension of previous computational modeling results
Samuel Taylor, Claire A. Lavalley, Navid Hakimi, Jennifer L. Stewart, Maria Ironside, Haixia Zheng, Evan White, Salvador Guinjoan, Martin P. Paulus, Ryan Smith
medRxiv 2023.04.03.23288037; doi: https://doi.org/10.1101/2023.04.03.23288037
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Active learning impairments in substance use disorders when resolving the explore-exploit dilemma: A replication and extension of previous computational modeling results
Samuel Taylor, Claire A. Lavalley, Navid Hakimi, Jennifer L. Stewart, Maria Ironside, Haixia Zheng, Evan White, Salvador Guinjoan, Martin P. Paulus, Ryan Smith
medRxiv 2023.04.03.23288037; doi: https://doi.org/10.1101/2023.04.03.23288037

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)